| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Bimatoprost | Bimatoprost 13, 14-Epoxide | VE007372 | View |
| Bimatoprost | Bimatoprost Acid 15-Epi Isopropyl Ester | VE007364 | View CAS 130273-87-9 |
| Bimatoprost | Bimatoprost Acid 15-Epi Methyl Ester | VE007365 | View CAS 122675-28-9 |
| Bimatoprost | Bimatoprost Acid 15-Epimer | VE007366 | View CAS 41639-71-8 |
| Bimatoprost | Bimatoprost Acid Impurity | VL3370001 | View CAS 38344-08-0 |
| Bimatoprost | Bimatoprost Acid Isopropyl Ester | VE007367 | View CAS 130209-76-6 |
| Bimatoprost | Bimatoprost Acid Methyl Ester | VE007368 | View CAS 38315-47-8 |
| Bimatoprost | Bimatoprost Cyclohexyl Amide | VE007373 | View |
| Bimatoprost | Bimatoprost Impurity 1 | VE007369 | View CAS 41162-19-0 |
| Bimatoprost | Bimatoprost Impurity 15 | VE0012737 | View |
| Bimatoprost | Bimatoprost Impurity 16 | VE0012722 | View CAS 856240-62-5 |
| Bimatoprost | Bimatoprost Impurity 17 | VE0012723 | View |
| Bimatoprost | Bimatoprost Impurity 2 | VE007370 | View CAS 76704-05-7 |
| Bimatoprost | Bimatoprost Impurity 20 | VE0014147 | View CAS 607351-44-0 |
| Bimatoprost | Bimatoprost Impurity 21 | VE0012725 | View CAS 2512198-63-7 |
| Bimatoprost | Bimatoprost Impurity 22 | VE0012726 | View |
| Bimatoprost | Bimatoprost Impurity 23 | VE0012736 | View |
| Bimatoprost | Bimatoprost Impurity 5 | VE0012715 | View CAS 155206-01-2 |
| Bimatoprost | Bimatoprost N-Cyclopropyl | VE007371 | View CAS 1138395-12-6 |
| Bimatoprost | Bimatoprost Oxirane Impurity | VE0016480 | View |
| Bimatoprost | N-Desethyl Bimatoprost | VE009329 | View CAS 155205-89-3 |
| Bimatoprost | 15 Epi Bimatoprost Impurity | VL3370002 | View CAS 1163135-92-9 |
| Bimatoprost | 15 Keto Bimatoprost Impurity | VL3370003 | View CAS 1163135-96-3 |
| Bimatoprost | 2-Nor Bimatoprost | VE009330 | View CAS 1356251-65-4 |
| Bimatoprost | 5, 6-Trans Bimatoprost Impurity | VL3370004 | View CAS 1163135-95-2 |
| Bimatoprost | 5-trans Bimatoprost Acid | VE0012735 | View CAS 1648894-84-1 |
| Bimatoprost | 9-epi Bimatoprost | VE0012727 | View |
Bimatoprost Related Compound
High pressure might occur when too much fluid accumulates within your eye. Bimatoprost aids in the drainage of fluid.
References
- Brubaker, Richard F. “Mechanism of Action of Bimatoprost (LumiganTM).” Survey of Ophthalmology, vol. 45, Elsevier BV, May 2001, pp. S347–51, https://doi.org/10.1016/s0039-6257(01)00213-2. Accessed 25 Aug. 2023.
- NHS Choices. Bimatoprost – Brand Names: Eyreida, Lumigan, Sturiban. 2023, www.nhs.uk/medicines/bimatoprost/#:~:text=Bimatoprost%20is%20a%20medicine%20that,cause%20vision%20loss%20or%20blindness. Accessed 25 Aug. 2023.
- Abhijeet Kumar Jha, et al. “Bimatoprost in Dermatology.” Indian Dermatology Online Journal, vol. 9, no. 3, Medknow, Jan. 2018, pp. 224–24, https://doi.org/10.4103/idoj.idoj_62_16. Accessed 25 Aug. 2023.
FAQ
What is the therapeutic class of bimatoprost?
Bimatoprost belongs to a family of drugs known as prostaglandin analogs. It reduces eye pressure by boosting the flow of natural ocular fluids out of the eye.
What is the use of bimatoprost in dermatology?
Bimatoprost appears to be effective in treating eyelash hypotrichosis. Bimatoprost’s efficacy in alopecia areata, androgenetic alopecia, vitiligo, and hypopigmentary diseases is still in its early stages and needs additional research.
What is the action of bimatoprost?
Bimatoprost increases the rate of aqueous humor flow by 13% during the day and 14% at night. Its ocular hypotensive activity is principally owing to a 26% decrease in tonographic outflow resistance. As a result, bimatoprost improves the pressure-sensitive outflow route.
